626-48-2 | 2,4-Dihydroxy-6-methylpyrimidine

Packsize	Purity	Availability	Price	Discounted Price
1g	98%	in stock	$15.00	$10.00
5g	98%	in stock	$16.00	$11.00
25g	98%	in stock	$22.00	$15.00
100g	98%	in stock	$40.00	$28.00
500g	98%	in stock	$95.00	$66.00

Description

• Catalog Number: AB43637
• Chemical Name: 2,4-Dihydroxy-6-methylpyrimidine
• CAS Number: 626-48-2
• Molecular Formula: C5H6N2O2
• Molecular Weight: 126.1133
• MDL Number: MFCD00006028
• SMILES: Cc1cc(O)nc(n1)O
• NSC Number: 9456

Computed Properties

• Complexity: 195
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 9
• Hydrogen Bond Acceptor Count: 2
• Hydrogen Bond Donor Count: 2
• XLogP3: -0.8

Upstream Synthesis Route

2,4-Dihydroxy-6-Methylpyrimidine is a versatile compound that plays a crucial role in chemical synthesis, particularly in the pharmaceutical and agrochemical industries. This specific molecule serves as a key intermediate in the synthesis of various bioactive compounds and pharmaceutical agents due to its unique structural properties and functional groups. Its ability to undergo diverse chemical reactions, such as acylation, alkylation, and condensation, makes it a valuable building block for the creation of complex organic molecules. Additionally, 2,4-Dihydroxy-6-Methylpyrimidine is utilized in the production of herbicides and fungicides, where its structural features contribute to the efficacy and specificity of these agricultural chemicals. By serving as a fundamental component in synthetic pathways, this compound enables the efficient and cost-effective production of a wide range of valuable substances with diverse applications.

Literature

• Effect of tissue-specific acetylcholinesterase inhibitor C-547 on α3β4 and αβεδ acetylcholine receptors in COS cells.

  European journal of pharmacology 20120805

• [Stages of bone regeneration and foundation of pharmacоlogical correction of the mandible reparative osteogenesis].

  Stomatologiia 20120101

• Trifluoromethylation of arenes and heteroarenes by means of photoredox catalysis.

  Nature 20111208

• Synthesis of various 5-alkoxymethyluracil analogues and structure-cytotoxic activity relationship study.

  Carbohydrate research 20111018

• Different sensitivities of rat skeletal muscles and brain to novel anti-cholinesterase agents, alkylammonium derivatives of 6-methyluracil (ADEMS).

  British journal of pharmacology 20110601

• Hydrothermal synthesis, experimental and theoretical characterization of a novel cocrystal compound in the 2:1 stoichiometric ratio containing 6-methyluracil and dipicolinic acid.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20110501

• Identifying chelators for metalloprotein inhibitors using a fragment-based approach.

  Journal of medicinal chemistry 20110127

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• 1,3-Bis(4-meth-oxy-benz-yl)-6-methyl-pyrimidine-2,4(1H,3H)-dione.

  Acta crystallographica. Section E, Structure reports online 20100701

• An evaluation of the chick cardiomyocyte micromass system for identification of teratogens in a blind trial.

  Reproductive toxicology (Elmsford, N.Y.) 20091201

• Mechanisms of cardiac muscle insensitivity to a novel acetylcholinesterase inhibitor C-547.

  Journal of cardiovascular pharmacology 20090201

• Different sensitivity of miniature endplate currents in rat external and internal intercostal muscles to the acetylcholinesterase inhibitor C-547 as compared with diaphragm and extensor digitorum longus.

  Physiological research 20090101

• Compounds with the dioxopyrimidine cycle inhibit cholinesterases from different groups of animals.

  Chemico-biological interactions 20080925

• Tetrakis- and tris(1-Methyluracil) complexes of Pt(II): formation and properties of a carbon-bonded nucleobase species as well as of heternonuclear derivatives.

  Inorganic chemistry 20071224

• The design and synthesis of N-1-alkylated-5-aminoarylalkylsubstituted-6-methyluracils as potential non-nucleoside HIV-1 RT inhibitors.

  Bioorganic & medicinal chemistry 20071201

• Selective oxidation of key functional groups in cyanotoxins during drinking water ozonation.

  Environmental science & technology 20070615

• Effect of a tetraalkylammonium derivative of 6-methyluracil from a new class of acetylcholinesterase inhibitors on the endplate potential amplitude in muscles of different function types under high-frequency nerve stimulation.

  Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections 20070101

• [Studying the nootropic effects of betamecil].

  Eksperimental'naia i klinicheskaia farmakologiia 20070101

• [Realization of optic activatory mechanism in laser-medication impact].

  Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury 20060101

• Different sensitivity of miniature endplate currents of the rat extensor digitorum longus, soleus and diaphragm muscles to a novel acetylcholinesterase inhibitor C-547.

  Physiological research 20060101

• Reaction of substituted pyrimidines with photochemically generated t-BuO* radicals.

  Indian journal of biochemistry & biophysics 20051201

• Atropisomeric property of 1-(2,6-difluorobenzyl)-3-[(2R)-amino-2-phenethyl]-5-(2-fluoro-3-methoxyphenyl)-6-methyluracil.

  Chirality 20051101

• Electron impact mass spectral study of 1,2-di-o-(m- and p-)nitro-(bromo-)benzyl-2-thio-6-methyluracils and 1,2-di-o-(m- and p-)nitro-(bromo-)benzyl-2-thio-5-bromo-6-methyluracils.

  Rapid communications in mass spectrometry : RCM 20050101

• Synthesis and structure-activity relationships of (R)-1-alkyl-3-[2-(2-amino)phenethyl]-5-(2-fluorophenyl)-6-methyluracils as human GnRH receptor antagonists.

  Bioorganic & medicinal chemistry letters 20040503

• Effect of tetraalkylammonium derivatives of 6-methyluracil on the endplate potentials of muscles of different functional types.

  Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections 20040101

• Antiparasitic activity of highly conjugated pyrimidine-2,4-dione derivatives.

  Farmaco (Societa chimica italiana : 1989) 20031201

• Synthesis and structure-activity relationships of 1-arylmethyl-3-(2-aminopropyl)-5-aryl-6-methyluracils as potent GnRH receptor antagonists.

  Bioorganic & medicinal chemistry letters 20031006

• Synthesis and structure-activity relationships of 1-arylmethyl-3-(1-methyl-2-amino)ethyl-5-aryl-6-methyluracils as antagonists of the human GnRH Receptor.

  Bioorganic & medicinal chemistry letters 20031006

• [Current methods for local drug therapy of infected wounds].

  Khirurgiia 20030101

• Pyrrolidino-DNA.

  Nucleosides, nucleotides & nucleic acids 20030101

• Biological activity of bacterial lectins and their molecular complexes with heterocyclic bis-adducts.

  Mikrobiolohichnyi zhurnal (Kiev, Ukraine : 1993) 20030101

• The acidity of uracil and uracil analogs in the gas phase: four surprisingly acidic sites and biological implications.

  Journal of the American Society for Mass Spectrometry 20020801

• Genotoxicity study of a new tetraalkylammonium derivative of 6-methyluracil (agent No. 547).

  Archives of toxicology 20020301

• [Photophoresis of methyluracil ointment in the complex treatment of temporomandibular pain syndrome].

  Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury 20020101

• [Studies of biological activity of mineral oil dialkyl disulfide (an experimental study)].

  Meditsina truda i promyshlennaia ekologiia 20020101

• [Morphological aspects of dermatotrophic action of methyluracil applied epicutaneously].

  Morfologiia (Saint Petersburg, Russia) 20020101

• [Surgical infected wound treatment in patients with severe gastrointestinal ulcer hemorrhage].

  Klinichna khirurhiia 20020101

• Effect of tetraalkylammonium derivative of 6-methyluracil on amplitude and temporal parameters of miniature endplate potentials in frog neuromuscular junction.

  Bulletin of experimental biology and medicine 20010501

• Tetraalkylammonium derivatives of 6-methyluracil, a new class of cholinesterase inhibitors: characteristics of interaction with cholinesterases from different groups of animals.

  Doklady. Biochemistry and biophysics 20010101

• Structure-activity relationship of ligands of uracil phosphoribosyltransferase from Toxoplasma gondii.

  Biochemical pharmacology 19940817